{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:20:34Z","timestamp":1771489234192,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,25]]},"DOI":"10.7759\/cureus.14099","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T10:20:27Z","timestamp":1616667627000},"source":"Crossref","is-referenced-by-count":26,"title":["Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine"],"prefix":"10.7759","author":[{"given":"Srikrishna V","family":"Malayala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisha","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Vasireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paavani","family":"Atluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"COVID-19 Coronavirus Pandemic. (2021). Accessed. March 13, 2021: https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"ref2","unstructured":"The COVID-19 candidate vaccine landscape and tracker. (2021). Accessed. March 13, 2021: https:\/\/www.who.int\/who-documents-detail\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson LA","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, et al.. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med. 2020, 383:1920-1931. 10.1056\/NEJMoa2022483","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden LR","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al.. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021, 384:403-416. 10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines DB","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009, 113:6511-21. 10.1182\/blood-2009-01-129155","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases","volume":"60","author":"Perricone C","year":"2014","unstructured":"Perricone C, Ceccarelli F, Nesher G, et al.. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014, 60:226-35. 10.1007\/s12026-014-8597-x","journal-title":"Immunol Res"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V76.5.859.859","article-title":"Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins","volume":"76","author":"George JN","year":"1990","unstructured":"George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood. 1990, 76:859-870.","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7913092","article-title":"Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients","volume":"2016","author":"Nagasaki J","year":"2016","unstructured":"Nagasaki J, Manabe M, Ido K, et al.. Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients. Case Rep Hematol. 2016, 2016:7913092. 10.1155\/2016\/7913092","journal-title":"Case Rep Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children","volume":"9","author":"Cecinati V","year":"2013","unstructured":"Cecinati V, Principi N, Brescia L, Giordano P, Esposito S. Vaccine administration and the development of immune thrombocytopenic purpura in children. Hum Vaccin Immunother. 2013, 9:1158-1162. 10.4161\/hv.23601","journal-title":"Hum Vaccin Immunother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children","volume":"121","author":"France EK","year":"2008","unstructured":"France EK, Glanz J, Xu S, et al.. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008, 121:e687-e692. 10.1542\/peds.2007-1578","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es LE","year":"2015","unstructured":"Guimar\u00e3es LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015, 100:190-209. 10.1016\/j.phrs.2015.08.003","journal-title":"Pharmacol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity--friends or foes?","volume":"30","author":"Kivity S","year":"2009","unstructured":"Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity--friends or foes?. Trends Immunol. 2009, 30:409-414. 10.1016\/j.it.2009.05.005","journal-title":"Trends Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8048-8","article-title":"Infections and autoimmunity: a panorama","volume":"34","author":"Pordeus V","year":"2008","unstructured":"Pordeus V, Szyper-Kravitz M, Levy RA, Vaz NM, Shoenfeld Y. Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol. 2008, 34:283-299. 10.1007\/s12016-007-8048-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.05.014","article-title":"On vaccine's adjuvants and autoimmunity: current evidence and future perspectives","volume":"14","author":"Pellegrino P","year":"2015","unstructured":"Pellegrino P, Clementi E, Radice S. On vaccine's adjuvants and autoimmunity: current evidence and future perspectives. Autoimmun Rev. 2015, 14:880-888. 10.1016\/j.autrev.2015.05.014","journal-title":"Autoimmun Rev"},{"key":"ref15","article-title":"Management of immune thrombocytopenic purpura: an update","volume":"12","author":"Warrier R","year":"2012","unstructured":"Warrier R, Chauhan A. Management of immune thrombocytopenic purpura: an update. Ochsner J. 2012, 12:221-227.","journal-title":"Ochsner J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black C","year":"2003","unstructured":"Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003, 55:107-111. 10.1046\/j.1365-2125.2003.01790.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref17","unstructured":"Death of Florida doctor after receiving COVID-19 vaccine under investigation. (Death of Florida doctor after receiving COVID\u201019 vaccine under investigation. USA Today). Accessed. March 13, 2021: https:\/\/www.usatoday.com\/story\/news\/health\/2021\/01\/06\/death-florida-doctor-following-pfizer-covid-19-vaccine-under-in...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26106","article-title":"Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine","author":"Tarawneh O","year":"2021","unstructured":"Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. Am J Hematol. 2021, 10.1002\/ajh.26106","journal-title":"Am J Hematol"},{"key":"ref19","unstructured":"'COVID arm'. Some develop delayed skin reaction after Moderna vaccine shot. (2021). Accessed: March 13, 2021: https:\/\/abc7ny.com\/covid-vaccine-reaction-side-effects-arm\/10398907\/."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11275","article-title":"A comprehensive review of congenital platelet disorders, thrombocytopenias and thrombocytopathies","volume":"12","author":"Mohan G","year":"2020","unstructured":"Mohan G, Malayala SV, Mehta P, Balla M. A comprehensive review of congenital platelet disorders, thrombocytopenias and thrombocytopathies. Cureus. 2020, 12:e11275. 10.7759\/cureus.11275","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/54984-purpuric-rash-and-thrombocytopenia-after-the-mrna-1273-moderna-covid-19-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:30Z","timestamp":1707506790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/54984-purpuric-rash-and-thrombocytopenia-after-the-mrna-1273-moderna-covid-19-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.14099","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,25]]}}}